Document Detail


Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.
MedLine Citation:
PMID:  22188636     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute or destabilized heart failure (DHF) is characterized by new or worsening signs and symptoms of heart failure leading to admission to an emergency department. Biomarkers may support the diagnosis, the prognosis and the management of DHF patients. The aim of this review article is to discuss and evaluate the clinical usefulness of both recognized and potential new biomarker tests for use in heart failure.
Authors:
Damien Gruson; Frédéric Thys; Franck Verschuren
Related Documents :
16105486 - Cardiac resynchronization therapy.
16598626 - Echocardiography-based optimization of cardiac resynchronization therapy in patients wi...
18715826 - Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients wi...
18445706 - Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.
3426896 - Chronic sinoatrial disorder (sick sinus syndrome): a possible result of cardiac ischaemia.
12960466 - Mri for the diagnosis of myocardial ischemia and viability.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Molecular diagnosis & therapy     Volume:  15     ISSN:  1179-2000     ISO Abbreviation:  Mol Diagn Ther     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-22     Completed Date:  2012-04-17     Revised Date:  2013-05-16    
Medline Journal Info:
Nlm Unique ID:  101264260     Medline TA:  Mol Diagn Ther     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  327-40     Citation Subset:  IM    
Affiliation:
Pôle de Recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium. damien.gruson@uclouvain.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / metabolism*
Emergencies
Extracellular Matrix / metabolism
Heart Failure / diagnosis*,  metabolism
Humans
Inflammation / metabolism
Myocytes, Cardiac / metabolism,  pathology
Neurotransmitter Agents / metabolism
Oxidative Stress
Prognosis
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Neurotransmitter Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.
Next Document:  Musculature Tissue Engineering to Repair Abdominal Wall Hernia.